Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • obischof
    Member
    • Jan 2011
    • 11

    #1

    Agilent Bioanalyzer 2100 detects no DNA

    Dear All,

    I have run into a huge problem with our seq platform. The problem is as follows. We have prepared chromatin using Mn digestion after PFA XL. We verified the appearance of primarily mono-nucleosomes in an agarose gel. We then went ahead to chip using different abs vs histone mods. The chipped material we again analysed on a gel and we saw nice bands in the vicinity of 100-200. This material we had analysed by the Agilent Bioanalyzer but zilch. So, we ignored this in the meantime because the gel was fine. Next, we prepared the library and ran it on the Bioanalyzer. Now, we saw a nice band around 200bp-ish, which we thought was fabulous (see photo). So, we made a test run on the Illumina Sequencer and to our suprise zilch. Now, what in heavens name is happening here. If someone could help me out.

    Thank you
    Attached Files
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #2
    Could your chipped material have been single stranded?

    Comment

    • obischof
      Member
      • Jan 2011
      • 11

      #3
      how could that be? what would that explain? Could we still build a library from that?

      Comment

      • ECO
        --Site Admin--
        • Oct 2007
        • 1360

        #4
        Well...depending on what dyes you're using on the gels where you see product, you may be seeing ssDNA that doesn't stain well or run predictably on the bioanalyzer.

        And you wouldn't be able to make a good library from ssDNA either...not sure what we're looking at on the bioanalyzer.

        It doesn't make sense that you got _nothing_ from the sequencing, because if you've truly amplified proper fragments you'd at least get sequence from that (maybe not biologically relevant). Was there any feedback as to what failed on the GA? No clusters? No mapped reads?

        Comment

        • epistatic
          Senior Member
          • Mar 2009
          • 129

          #5
          The majority of the ChIP-DNA I get for library preps have a large quantity of ssDNA. The process of removing the cross-linking is rough and possibly denatures the sample. There are also some that think the IP also pulls down targets naturally bound to ssDNA (but I would think in the minority).

          For all ChIP, the nanodrop was misleading for concentration. I now require dsDNA specific assays as initial QC/QA (picogreen, Qubit).

          If there is a question of the origin of the DNA on the second bioanalyzer traces, dilute some and PCR with the Illumina primers. You should only see an increase of the material with adapters.

          Comment

          • obischof
            Member
            • Jan 2011
            • 11

            #6
            We had no clusters that passed the internal QC of GA, though the first cycle was OK.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
              by SEQadmin2



              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

              Despite this, “CRISPR helped turn genome editing from a specialized technique into
              ...
              07-31-2026, 11:01 AM
            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 08-13-2026, 12:22 PM
            0 responses
            31 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-11-2026, 10:35 AM
            0 responses
            24 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-06-2026, 07:41 AM
            0 responses
            38 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-03-2026, 10:13 AM
            0 responses
            51 views
            0 reactions
            Last Post SEQadmin2  
            Working...